IBDEI0TK ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,13301,1,4,0)
;;=4^H35.3122
;;^UTILITY(U,$J,358.3,13301,2)
;;=^5138507
;;^UTILITY(U,$J,358.3,13302,0)
;;=H35.3123^^51^633^10
;;^UTILITY(U,$J,358.3,13302,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13302,1,3,0)
;;=3^NonEx AMD,OS,Adv Atrpc w/o Sbfvl Invlv
;;^UTILITY(U,$J,358.3,13302,1,4,0)
;;=4^H35.3123
;;^UTILITY(U,$J,358.3,13302,2)
;;=^5138508
;;^UTILITY(U,$J,358.3,13303,0)
;;=H35.3124^^51^633^11
;;^UTILITY(U,$J,358.3,13303,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13303,1,3,0)
;;=3^NonEx AMD,OS,Adv Atrpc w/ Sbfvl Invlv
;;^UTILITY(U,$J,358.3,13303,1,4,0)
;;=4^H35.3124
;;^UTILITY(U,$J,358.3,13303,2)
;;=^5138509
;;^UTILITY(U,$J,358.3,13304,0)
;;=H35.3110^^51^633^2
;;^UTILITY(U,$J,358.3,13304,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13304,1,3,0)
;;=3^NonEx AMD,OD,Stage Unspec
;;^UTILITY(U,$J,358.3,13304,1,4,0)
;;=4^H35.3110
;;^UTILITY(U,$J,358.3,13304,2)
;;=^5138500
;;^UTILITY(U,$J,358.3,13305,0)
;;=H35.3111^^51^633^3
;;^UTILITY(U,$J,358.3,13305,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13305,1,3,0)
;;=3^NonEx AMD,OD,Early Dry Stage
;;^UTILITY(U,$J,358.3,13305,1,4,0)
;;=4^H35.3111
;;^UTILITY(U,$J,358.3,13305,2)
;;=^5138501
;;^UTILITY(U,$J,358.3,13306,0)
;;=H35.3112^^51^633^4
;;^UTILITY(U,$J,358.3,13306,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13306,1,3,0)
;;=3^NonEx AMD,OD,Intermed Dry Stage
;;^UTILITY(U,$J,358.3,13306,1,4,0)
;;=4^H35.3112
;;^UTILITY(U,$J,358.3,13306,2)
;;=^5138502
;;^UTILITY(U,$J,358.3,13307,0)
;;=H35.3113^^51^633^5
;;^UTILITY(U,$J,358.3,13307,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13307,1,3,0)
;;=3^NonEx AMD,OD,Adv Atrpc w/o Sbfvl Invlv
;;^UTILITY(U,$J,358.3,13307,1,4,0)
;;=4^H35.3113
;;^UTILITY(U,$J,358.3,13307,2)
;;=^5138503
;;^UTILITY(U,$J,358.3,13308,0)
;;=H35.3114^^51^633^6
;;^UTILITY(U,$J,358.3,13308,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13308,1,3,0)
;;=3^NonEx AMD,OD,Adv Atrpc w/ Subfvl Invlv
;;^UTILITY(U,$J,358.3,13308,1,4,0)
;;=4^H35.3114
;;^UTILITY(U,$J,358.3,13308,2)
;;=^5138504
;;^UTILITY(U,$J,358.3,13309,0)
;;=H32.^^51^634^12
;;^UTILITY(U,$J,358.3,13309,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13309,1,3,0)
;;=3^Chorioretinal Disorders,Secondary,Unspec
;;^UTILITY(U,$J,358.3,13309,1,4,0)
;;=4^H32.
;;^UTILITY(U,$J,358.3,13309,2)
;;=^5005489
;;^UTILITY(U,$J,358.3,13310,0)
;;=H30.93^^51^634^11
;;^UTILITY(U,$J,358.3,13310,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13310,1,3,0)
;;=3^Chorioretinal Inflammation,Unspec,OU
;;^UTILITY(U,$J,358.3,13310,1,4,0)
;;=4^H30.93
;;^UTILITY(U,$J,358.3,13310,2)
;;=^5005435
;;^UTILITY(U,$J,358.3,13311,0)
;;=H30.91^^51^634^9
;;^UTILITY(U,$J,358.3,13311,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13311,1,3,0)
;;=3^Chorioretinal Inflammation,Unspec,OD
;;^UTILITY(U,$J,358.3,13311,1,4,0)
;;=4^H30.91
;;^UTILITY(U,$J,358.3,13311,2)
;;=^5133481
;;^UTILITY(U,$J,358.3,13312,0)
;;=H30.92^^51^634^10
;;^UTILITY(U,$J,358.3,13312,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13312,1,3,0)
;;=3^Chorioretinal Inflammation,Unspec,OS
;;^UTILITY(U,$J,358.3,13312,1,4,0)
;;=4^H30.92
;;^UTILITY(U,$J,358.3,13312,2)
;;=^5133482
;;^UTILITY(U,$J,358.3,13313,0)
;;=H31.003^^51^634^15
;;^UTILITY(U,$J,358.3,13313,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,13313,1,3,0)
;;=3^Chorioretinal Scars,Unspec,OU
;;^UTILITY(U,$J,358.3,13313,1,4,0)
;;=4^H31.003
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0TK 3777 printed Sep 23, 2025@19:31:29 Page 2
IBDEI0TK ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,13301,1,4,0)
+2 ;;=4^H35.3122
+3 ;;^UTILITY(U,$J,358.3,13301,2)
+4 ;;=^5138507
+5 ;;^UTILITY(U,$J,358.3,13302,0)
+6 ;;=H35.3123^^51^633^10
+7 ;;^UTILITY(U,$J,358.3,13302,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,13302,1,3,0)
+10 ;;=3^NonEx AMD,OS,Adv Atrpc w/o Sbfvl Invlv
+11 ;;^UTILITY(U,$J,358.3,13302,1,4,0)
+12 ;;=4^H35.3123
+13 ;;^UTILITY(U,$J,358.3,13302,2)
+14 ;;=^5138508
+15 ;;^UTILITY(U,$J,358.3,13303,0)
+16 ;;=H35.3124^^51^633^11
+17 ;;^UTILITY(U,$J,358.3,13303,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,13303,1,3,0)
+20 ;;=3^NonEx AMD,OS,Adv Atrpc w/ Sbfvl Invlv
+21 ;;^UTILITY(U,$J,358.3,13303,1,4,0)
+22 ;;=4^H35.3124
+23 ;;^UTILITY(U,$J,358.3,13303,2)
+24 ;;=^5138509
+25 ;;^UTILITY(U,$J,358.3,13304,0)
+26 ;;=H35.3110^^51^633^2
+27 ;;^UTILITY(U,$J,358.3,13304,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,13304,1,3,0)
+30 ;;=3^NonEx AMD,OD,Stage Unspec
+31 ;;^UTILITY(U,$J,358.3,13304,1,4,0)
+32 ;;=4^H35.3110
+33 ;;^UTILITY(U,$J,358.3,13304,2)
+34 ;;=^5138500
+35 ;;^UTILITY(U,$J,358.3,13305,0)
+36 ;;=H35.3111^^51^633^3
+37 ;;^UTILITY(U,$J,358.3,13305,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,13305,1,3,0)
+40 ;;=3^NonEx AMD,OD,Early Dry Stage
+41 ;;^UTILITY(U,$J,358.3,13305,1,4,0)
+42 ;;=4^H35.3111
+43 ;;^UTILITY(U,$J,358.3,13305,2)
+44 ;;=^5138501
+45 ;;^UTILITY(U,$J,358.3,13306,0)
+46 ;;=H35.3112^^51^633^4
+47 ;;^UTILITY(U,$J,358.3,13306,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,13306,1,3,0)
+50 ;;=3^NonEx AMD,OD,Intermed Dry Stage
+51 ;;^UTILITY(U,$J,358.3,13306,1,4,0)
+52 ;;=4^H35.3112
+53 ;;^UTILITY(U,$J,358.3,13306,2)
+54 ;;=^5138502
+55 ;;^UTILITY(U,$J,358.3,13307,0)
+56 ;;=H35.3113^^51^633^5
+57 ;;^UTILITY(U,$J,358.3,13307,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,13307,1,3,0)
+60 ;;=3^NonEx AMD,OD,Adv Atrpc w/o Sbfvl Invlv
+61 ;;^UTILITY(U,$J,358.3,13307,1,4,0)
+62 ;;=4^H35.3113
+63 ;;^UTILITY(U,$J,358.3,13307,2)
+64 ;;=^5138503
+65 ;;^UTILITY(U,$J,358.3,13308,0)
+66 ;;=H35.3114^^51^633^6
+67 ;;^UTILITY(U,$J,358.3,13308,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,13308,1,3,0)
+70 ;;=3^NonEx AMD,OD,Adv Atrpc w/ Subfvl Invlv
+71 ;;^UTILITY(U,$J,358.3,13308,1,4,0)
+72 ;;=4^H35.3114
+73 ;;^UTILITY(U,$J,358.3,13308,2)
+74 ;;=^5138504
+75 ;;^UTILITY(U,$J,358.3,13309,0)
+76 ;;=H32.^^51^634^12
+77 ;;^UTILITY(U,$J,358.3,13309,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,13309,1,3,0)
+80 ;;=3^Chorioretinal Disorders,Secondary,Unspec
+81 ;;^UTILITY(U,$J,358.3,13309,1,4,0)
+82 ;;=4^H32.
+83 ;;^UTILITY(U,$J,358.3,13309,2)
+84 ;;=^5005489
+85 ;;^UTILITY(U,$J,358.3,13310,0)
+86 ;;=H30.93^^51^634^11
+87 ;;^UTILITY(U,$J,358.3,13310,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,13310,1,3,0)
+90 ;;=3^Chorioretinal Inflammation,Unspec,OU
+91 ;;^UTILITY(U,$J,358.3,13310,1,4,0)
+92 ;;=4^H30.93
+93 ;;^UTILITY(U,$J,358.3,13310,2)
+94 ;;=^5005435
+95 ;;^UTILITY(U,$J,358.3,13311,0)
+96 ;;=H30.91^^51^634^9
+97 ;;^UTILITY(U,$J,358.3,13311,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,13311,1,3,0)
+100 ;;=3^Chorioretinal Inflammation,Unspec,OD
+101 ;;^UTILITY(U,$J,358.3,13311,1,4,0)
+102 ;;=4^H30.91
+103 ;;^UTILITY(U,$J,358.3,13311,2)
+104 ;;=^5133481
+105 ;;^UTILITY(U,$J,358.3,13312,0)
+106 ;;=H30.92^^51^634^10
+107 ;;^UTILITY(U,$J,358.3,13312,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,13312,1,3,0)
+110 ;;=3^Chorioretinal Inflammation,Unspec,OS
+111 ;;^UTILITY(U,$J,358.3,13312,1,4,0)
+112 ;;=4^H30.92
+113 ;;^UTILITY(U,$J,358.3,13312,2)
+114 ;;=^5133482
+115 ;;^UTILITY(U,$J,358.3,13313,0)
+116 ;;=H31.003^^51^634^15
+117 ;;^UTILITY(U,$J,358.3,13313,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,13313,1,3,0)
+120 ;;=3^Chorioretinal Scars,Unspec,OU
+121 ;;^UTILITY(U,$J,358.3,13313,1,4,0)
+122 ;;=4^H31.003
